Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 835.74 | 51.35 | 1,034.98 | ||
| High | 847.00 | 52.57 | 1,058.69 | ||
| Low | 826.64 | 51.35 | 1,029.46 | ||
| Last | 834.04 | 52.41 | 1,039.78 | ||
| Change | +7.40 | +0.45 | +1.66 | ||
| Percent Change | +0.90% | +0.87% | +0.16% | ||
| Volume | 786,900 | 2,404,900 | 377,300 | ||
| 20-Day Average Volume | 816,200 | 3,945,950 | 310,200 | ||
| Previous | 826.64 | 51.96 | 1,038.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 776.69 | 51.72 | 903.01 | ||
| 20-Day Raw Stochastic | 93.09% | 51.26% | 91.86% | ||
| 20-Day Relative Strength | 73.79 | 52.61 | 68.65 | ||
| Weighted Alpha | +43.59 | +23.00 | +55.90 | ||
| Today's Opinion | 40% Buy | 40% Sell | 100% Buy | ||
| Yesterday's Opinion | 40% Buy | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 56% Sell | 32% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.80% since 08/14/26 | +5.84% since 08/14/26 | +22.14% since 08/14/26 | ||
| Low | 795.73 on 08/17/26 | 49.88 on 08/17/26 | 925.62 on 08/17/26 | ||
| High | 847.00 on 08/21/26 | 52.94 on 08/19/26 | 1,058.69 on 08/21/26 | ||
| 1-Month | |||||
| %Chg | +23.53% since 07/21/26 | +3.21% since 07/21/26 | +18.87% since 07/21/26 | ||
| Low | 637.80 on 07/23/26 | 48.86 on 08/14/26 | 826.45 on 08/03/26 | ||
| High | 847.00 on 08/21/26 | 55.78 on 07/28/26 | 1,058.69 on 08/21/26 | ||
| 3-Month | |||||
| %Chg | +29.79% since 05/21/26 | +1.71% since 05/21/26 | +27.39% since 05/21/26 | ||
| Low | 591.52 on 06/02/26 | 48.57 on 06/02/26 | 793.21 on 06/03/26 | ||
| High | 847.00 on 08/21/26 | 55.78 on 07/28/26 | 1,058.69 on 08/21/26 | ||
| 6-Month | |||||
| %Chg | +6.97% since 02/20/26 | -11.95% since 02/20/26 | +23.14% since 02/20/26 | ||
| Low | 591.52 on 06/02/26 | 48.57 on 06/02/26 | 661.85 on 03/20/26 | ||
| High | 847.00 on 08/21/26 | 59.94 on 02/25/26 | 1,058.69 on 08/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 85,868,592 | 106,009,600 | 65,049,680 | ||
| Shares Outstanding, K | 102,955 | 2,022,698 | 62,561 | ||
| Annual Sales, $M | 14,342,900,000 | 43,077,970,000 | 4,248,050,000 | ||
| Annual Net Income, $M | 4,504,900,000 | 7,537,690,000 | 1,292,040,000 | ||
| Last Qtr Sales, $M | 4,290,700,000 | 11,285,720,000 | 1,542,000,000 | ||
| Last Qtr Income, $M | 1,296,900,000 | 583,810,000 | 472,000,000 | ||
| 60-Month Beta | 0.22 | 0.36 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 14.29 on 07/30/26 | 1.36 on 07/28/26 | 7.32 on 07/23/26 | ||
| Latest Earnings Date | 10/27/26 | 11/04/26 | 10/29/26 | ||
| Most Recent Dividend | 0.940 on 08/18/26 | 0.444 on 08/14/26 | N/A | ||
| Next Ex-Dividend Date | 08/18/26 | 08/14/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 21.22 | 10.92 | 39.87 | ||